• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » T.V. Padma

Articles by T.V. Padma

India’s pharma sector continues to face IP challenges: Report

March 29, 2017
By T.V. Padma
NEW DELHI – India’s business environment will remain highly challenging for innovative pharmaceutical firms, according to BMI Research. The report comes on the heels of the February U.S. Chamber International IP Index, which ranks India very low in intellectual property (IP) – 43rd among 45 countries that represent 90 percent of the global GDP.
Read More

India's pharma sector continues to face IP challenges: Report

March 27, 2017
By T.V. Padma
NEW DELHI – India's business environment will remain highly challenging for innovative pharmaceutical firms, according to BMI Research. The report comes on the heels of the February U.S. Chamber International IP Index, which ranks India very low in intellectual property (IP) – 43rd among 45 countries that represent 90 percent of the global GDP.
Read More

Med-tech industry up in arms over aggressive Indian stent pricing move

Feb. 28, 2017
By T.V. Padma

Market for prefilled syringes highlights growth in India, other developing nations

Feb. 21, 2017
By T.V. Padma

Pharma chiefs: India must shift focus from manufacturing to design

Feb. 13, 2017
By T.V. Padma
HYDERABAD – India is registering healthy growth in pharma exports that are expected increase between 8 percent and 10 percent this year and the next, according to government estimates. It's powered by the country's strength as a generics manufacturing hub.
Read More

India an emerging life sciences 'powerhouse'; still weak on innovation

Feb. 9, 2017
By T.V. Padma
HYDERABAD, India – Smaller domestic and regional pharmaceutical and biotech companies are expanding their footprint in Asia while using the region as a launch pad to emerge as significant global players and to tap a growing ecosystem of biotech-related business. Many of those companies are in India, where policy initiatives and plenty of unmet needs have come together to encourage investment in the space.
Read More

Industry bemoans lack of incentives despite biotech budget hike

Feb. 8, 2017
By T.V. Padma
NEW DELHI – A significant boost to India's Department of Biotechnology (DBT) in the country's latest budget has nevertheless left the domestic industry unimpressed and unenthused, with critics noting there are few new incentives to help the sector.
Read More

Industry bemoans lack of incentives despite biotech budget hike

Feb. 7, 2017
By T.V. Padma
NEW DELHI – A significant boost to India’s Department of Biotechnology (DBT) in the country’s latest budget has nevertheless left the domestic industry unimpressed and unenthused, with critics noting there are few new incentives to help the sector.
Read More

India's national budget leaves domestic med techs frustrated

Feb. 3, 2017
By T.V. Padma

India battles growing antibiotic resistance, noncompliant sales

Feb. 1, 2017
By T.V. Padma
NEW DELHI –In the wake of the death of a U.S. woman who had been infected with a drug-resistant bug in India, the country's drug regulator has ordered all companies involved in the drug supply chain system to strictly follow the country's guidelines in the Drugs and Cosmetics Act on the sale of medicines.
Read More
Previous 1 2 … 6 7 8 9 10 11 12 13 14 … 27 28 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 8, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 8, 2025.
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 8, 2025
  • Kidney disease illustration

    Prokidney produces positive phase II CKD data, thunderous stock surge

    BioWorld
    A mixed bag of top-line phase II data prompted stellar stock results for Prokidney Corp. and its chronic kidney disease (CKD) and diabetes therapy, rilparencel....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe